Skip to main content
logo
Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.1651
+0.0051 (3.19%)
At close: Sep 16, 2026, 4:00 PM EDT
0.1562
-0.0089 (-5.39%)
Pre-market: Sep 17, 2026, 8:58 AM EDT

MTNB Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-6.69-10.35-24.25-22.94-21-23.28
Depreciation & Amortization
0.280.460.970.940.90.78
Other Amortization
----0.210.25
Loss (Gain) From Sale of Assets
0.21-0.04-000
Asset Writedown & Restructuring Costs
--4.43---
Stock-Based Compensation
0.691.023.24.955.234.29
Other Operating Activities
-0.133.4-0.10.110.291.2
Change in Accounts Payable
0.680.22-0.42-0.1-0.320.59
Change in Other Net Operating Assets
-1.46-1.730.291.77-4.470.95
Operating Cash Flow
-6.42-7.01-15.89-15.28-19.16-15.22
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
----0.22-0.89-0.26
Sale of Property, Plant & Equipment
0.340.34----
Investment in Securities
--9.2113.465.7717.03
Investing Cash Flow
0.340.349.2113.244.8816.77

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--0.01-0.01-0.01-0.02-0.03
Total Debt Repaid
-0.01-0.01-0.01-0.01-0.02-0.03
Net Debt Issued (Repaid)
-0.01-0.01-0.01-0.01-0.02-0.03
Issuance of Common Stock
0.130.139.18-0.17
Other Financing Activities
--0.03----
Financing Cash Flow
0.123.399.17-0.010.086.97

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-5.96-3.292.5-2.04-14.28.51

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-6.42-7.01-15.89-15.5-20.05-15.48
Free Cash Flow Growth
------
Free Cash Flow Margin
----1413.87%-628.86%-46918.18%
Free Cash Flow Per Share
-1.05-1.28-3.27-3.57-4.62-3.68
Levered Free Cash Flow
-2.45-3.34-7.45-6.96-14.39-8.25
Unlevered Free Cash Flow
-2.45-3.34-7.45-6.96-14.6-8.5

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-0.78-1.51-0.131.67-4.791.54
SEC Filings: 10-K · 10-Q